Donald J. Kellerman
Net Worth
Last updated:
What is Donald J. Kellerman net worth?
The estimated net worth of Dr. Donald J. Kellerman is at least $5,272,231 as of 31 Mar 2022. He owns shares worth $31,410 as insider, has earned $841 from insider trading and has received compensation worth at least $5,239,980 in Zosano Pharma Corporation.
What is the salary of Donald J. Kellerman?
Dr. Donald J. Kellerman salary is $582,220 per year as Vice President of Clinical Devel. & Medical Affairs in Zosano Pharma Corporation.
How old is Donald J. Kellerman?
Dr. Donald J. Kellerman is 70 years old, born in 1955.
What stocks does Donald J. Kellerman currently own?
As insider, Dr. Donald J. Kellerman owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Zosano Pharma Corporation (ZSAN) | Vice President of Clinical Devel. & Medical Affairs | 56,331 | $0.56 | $31,410 |
What does Zosano Pharma Corporation do?
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Donald J. Kellerman insider trading
Zosano Pharma Corporation
Dr. Donald J. Kellerman has made 2 insider trades between 2016-2022, according to the Form 4 filled with the SEC. Most recently he sold 4,006 units of ZSAN stock worth $841 on 31 Mar 2022.
The largest trade he's ever made was exercising 15,920 units of ZSAN stock on 19 Aug 2016. As of 31 Mar 2022 he still owns at least 56,331 units of ZSAN stock.
Zosano Pharma key executives
Zosano Pharma Corporation executives and other stock owners filed with the SEC:
- Dr. Donald J. Kellerman (70) Vice President of Clinical Devel. & Medical Affairs
- Mr. Steven Lo (58) Senior Vice President of Operations, Pres, Chief Executive Officer & Director